Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk

Azad, Arun A.; Armstrong, Andrew J.; Alcaraz, Antonio; Szmulewitz, Russell Z.; Petrylak, Daniel P.; Holzbeierlein, Jeffrey; Villers, Arnauld; Alekseev, Boris; Iguchi, Taro; Shore, Neal D.; Gomez-Veiga, Francisco; Rosbrook, Brad; Lee, Ho-Jin; Haas, Gabriel P.; Stenzl, Arnulf

Publikationsdienste
→
Universitätsbibliographie
→
4 Medizinische Fakultät
→
Dokumentanzeige

« zurück

Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk

Autor(en):

Azad, Arun A.; Armstrong, Andrew J.; Alcaraz, Antonio; Szmulewitz, Russell Z.; Petrylak, Daniel P.; Holzbeierlein, Jeffrey; Villers, Arnauld; Alekseev, Boris; Iguchi, Taro; Shore, Neal D.; Gomez-Veiga, Francisco; Rosbrook, Brad; Lee, Ho-Jin; Haas, Gabriel P.; Stenzl, Arnulf

Tübinger Autor(en):

Stenzl, Arnulf

Erschienen in:

Prostate Cancer and Prostatic Diseases (2022), Bd. 25, H. 2, S. 274-282

Verlagsangabe:

Springernature

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1038/s41391-021-00436-y

ISSN:

1365-7852